MedinCell S.A.
MDCLF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -15.4% | 70.7% | 150.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 0% | 100% | 100% | 91.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -127.5% | -24.5% | -76.9% | -306.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -138.5% | -24% | -154.4% | -448.3% |
| EPS Diluted | -0.57 | -0.13 | -0.5 | -0.58 |
| % Growth | -338.5% | 74% | 13.8% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |